Home › Sleep Disorders › Florida › Miami
Sleep Disorders clinical trials in Miami, FL
4 studies for Sleep Disorders are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Miami, Florida, Miami
- Miami, Florida, Miami
- Miami, Florida, Miami
- and 1 more
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Miami
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
- Alkermes Investigational Site, Miami
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
RecruitingPhase 3
- Alkermes Investigational Site, Miami
About Sleep Disorders
Getting a good sleep is vital to your health, but many Americans don't get enough. Learn about sleep disorders, treatments, and good sleep habits.
More about Sleep Disorders on MedlinePlus
Sleep Disorders trials in other cities
- San Antonio, TX6 studies
- Lansing, MI5 studies
- Cincinnati, OH5 studies
- Sugar Land, TX5 studies
- Charlotte, NC5 studies
- Orlando, FL5 studies
- Brandon, FL5 studies
- Dallas, TX4 studies
- Macon, GA4 studies
- Austin, TX4 studies
- Columbia, SC4 studies
- Atlanta, GA4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.